Kevin Conroy, Chairman and CEO of Exact Sciences, and President and CEO of Third Wave Technologies, shared a post on LinkedIn:
“Today, our team launched the Cancerguard test, our multi-cancer early detection (MCED) test, and our third successful launch this year.
In the U.S., nearly 70 percent of cancer cases and deaths come from cancers with no recommended screening. With just a single blood draw, the Cancerguard test can detect signals from multiple cancers, often before symptoms appear. By finding cancer earlier, before it spreads, we can give patients a better chance at successful treatment. This launch marks a major step forward for patients and offers a clear glimpse into the future of cancer screening.
A huge thank you to the Exact Sciences team for making this possible!”
Kevin Conroy/LinkedIn
More posts featuring Kevin Conroy.